Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

NCT06700421 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Locally Advanced Non-small Cell Lung Cancer

Interventions

DRUG: Adebrelimab + Apatinib

Sponsor

Wei Zhou